Aligos Therapeutics Cash from Operations (TTM) Insights

Aligos Therapeutics Inc (ALGS)

0.7887 -0.03 (-3.58%) USD | NASDAQ | Apr 26, 16:00

0.7887 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	-79.00M
September 30, 2023	-73.12M
June 30, 2023	-69.92M
March 31, 2023	-81.34M
December 31, 2022	-79.39M
September 30, 2022	-100.09M
June 30, 2022	-108.32M

Date	Value
March 31, 2022	-106.30M
December 31, 2021	-115.66M
September 30, 2021	-97.87M
June 30, 2021	-89.06M
March 31, 2021	-83.74M
December 31, 2020	-74.26M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-115.66M

Minimum

Dec 2021

-69.92M

Maximum

Jun 2023

-89.08M

Average

-83.74M

Median

Mar 2021

Cash from Operations (TTM) Benchmarks